Olaf R.F. Mook

2.2k total citations
26 papers, 1.6k citations indexed

About

Olaf R.F. Mook is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Olaf R.F. Mook has authored 26 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Olaf R.F. Mook's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and MicroRNA in disease regulation (4 papers). Olaf R.F. Mook is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and MicroRNA in disease regulation (4 papers). Olaf R.F. Mook collaborates with scholars based in Netherlands, Denmark and United States. Olaf R.F. Mook's co-authors include Wilma M. Frederiks, Cornelis J.F. Van Noorden, Frank Baas, Kees Fluiter, Marit B. de Wissel, Febe van Maldegem, Peter Henneman, Jesper Wengel, Ronald H. Lekanne Deprez and Heleen Vreeling‐Sindelárová and has published in prestigious journals such as Blood, Hepatology and Movement Disorders.

In The Last Decade

Olaf R.F. Mook

26 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olaf R.F. Mook Netherlands 18 919 498 361 229 122 26 1.6k
C. Theresa Vincent United States 18 1.1k 1.2× 308 0.6× 548 1.5× 229 1.0× 140 1.1× 23 1.6k
Kristina Rafidi United States 9 1.1k 1.2× 478 1.0× 361 1.0× 155 0.7× 118 1.0× 9 1.7k
Vivian W.Y. Wong United States 8 995 1.1× 219 0.4× 435 1.2× 171 0.7× 189 1.5× 9 1.6k
Hilary M. Collins United Kingdom 22 1.1k 1.2× 667 1.3× 546 1.5× 121 0.5× 102 0.8× 36 2.0k
Kristin F. Wilson United States 21 1.3k 1.4× 591 1.2× 199 0.6× 125 0.5× 131 1.1× 30 1.8k
Praveen Bhoopathi United States 27 964 1.0× 500 1.0× 628 1.7× 195 0.9× 403 3.3× 52 1.9k
H Y Min United States 13 760 0.8× 421 0.8× 251 0.7× 134 0.6× 309 2.5× 14 1.7k
Yan Jin China 23 773 0.8× 309 0.6× 262 0.7× 153 0.7× 219 1.8× 74 1.3k
Jialiang Hu China 15 634 0.7× 707 1.4× 434 1.2× 77 0.3× 154 1.3× 31 1.4k
Takanori Tsuji United States 21 1.3k 1.4× 402 0.8× 598 1.7× 135 0.6× 192 1.6× 30 2.0k

Countries citing papers authored by Olaf R.F. Mook

Since Specialization
Citations

This map shows the geographic impact of Olaf R.F. Mook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf R.F. Mook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf R.F. Mook more than expected).

Fields of papers citing papers by Olaf R.F. Mook

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olaf R.F. Mook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf R.F. Mook. The network helps show where Olaf R.F. Mook may publish in the future.

Co-authorship network of co-authors of Olaf R.F. Mook

This figure shows the co-authorship network connecting the top 25 collaborators of Olaf R.F. Mook. A scholar is included among the top collaborators of Olaf R.F. Mook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olaf R.F. Mook. Olaf R.F. Mook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alaamery, Manal, Nour Albesher, Fahad Alhabshan, et al.. (2023). TGFBR1 Variants Can Associate with Non-Syndromic Congenital Heart Disease without Aortopathy. Journal of Cardiovascular Development and Disease. 10(11). 455–455. 1 indexed citations
2.
Lint, Freyja H.M. van, Olaf R.F. Mook, Mariëlle Alders, et al.. (2019). Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance. Netherlands Heart Journal. 27(6). 304–309. 41 indexed citations
3.
Christiaans, Imke, Olaf R.F. Mook, Mariëlle Alders, Hennie Bikker, & Ronald H. Lekanne Deprez. (2019). Large next-generation sequencing gene panels in genetic heart disease: challenges in clinical practice. Netherlands Heart Journal. 27(6). 299–303. 7 indexed citations
4.
Naue, Jana, Huub C. J. Hoefsloot, Olaf R.F. Mook, et al.. (2017). Chronological age prediction based on DNA methylation: Massive parallel sequencing and random forest regression. Forensic Science International Genetics. 31. 19–28. 129 indexed citations
5.
Henneman, Peter, Andrea Venema, Adri N. Mul, et al.. (2016). Cow’s milk allergy in Dutch children: an epigenetic pilot survey. Clinical and Translational Allergy. 6(1). 16–16. 30 indexed citations
6.
Groen, J, Katja Ritz, Hamid Jalalzadeh, et al.. (2015). RELN rare variants in myoclonus‐dystonia. Movement Disorders. 30(3). 415–419. 17 indexed citations
7.
Alders, Mariëlle, Lihadh Al‐Gazali, Bruno Dallapiccola, et al.. (2014). Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Human Genetics. 133(9). 1161–1167. 103 indexed citations
8.
Weiss, Marjan M., Bert van der Zwaag, Jan D.H. Jongbloed, et al.. (2013). Best Practice Guidelines for the Use of Next-Generation Sequencing Applications in Genome Diagnostics: A National Collaborative Study of Dutch Genome Diagnostic Laboratories. Human Mutation. 34(10). 1313–1321. 76 indexed citations
9.
Mook, Olaf R.F., Martin A. Haagmans, Frank Baas, et al.. (2013). Targeted sequence capture and GS-FLX Titanium sequencing of 23 hypertrophic and dilated cardiomyopathy genes: implementation into diagnostics. Journal of Medical Genetics. 50(9). 614–626. 27 indexed citations
10.
Christiaans, Imke, Phil Barnett, Ronald H. Lekanne Deprez, et al.. (2012). A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(4). 833–839. 15 indexed citations
11.
Laursen, Maria Bach, Malgorzata Maria Pakula, Shan Gao, et al.. (2010). Utilization of unlocked nucleic acid (UNA) to enhance siRNA performance in vitro and in vivo. Molecular BioSystems. 6(5). 862–870. 93 indexed citations
12.
13.
Fluiter, Kees, Olaf R.F. Mook, Jeroen Vreijling, et al.. (2009). Filling the gap in LNAantisense oligo gapmers: the effects of unlocked nucleic acid (UNA) and 4′- C -hydroxymethyl-DNA modifications on RNase H recruitment and efficacy of an LNA gapmer. Molecular BioSystems. 5(8). 838–843. 36 indexed citations
14.
Mook, Olaf R.F., Frank Baas, Marit B. de Wissel, & Kees Fluiter. (2009). Allele-specific cancer cell killing in vitro and in vivo targeting a single-nucleotide polymorphism in POLR2A. Cancer Gene Therapy. 16(6). 532–538. 10 indexed citations
15.
Mook, Olaf R.F., et al.. (2008). Interactions between colon cancer cells and hepatocytes in rats in relation to metastasis. Journal of Cellular and Molecular Medicine. 12(5b). 2052–2061. 22 indexed citations
16.
Fluiter, Kees, Olaf R.F. Mook, & Frank Baas. (2008). The Therapeutic Potential of LNA-modified siRNAs: Reduction of Off-target Effects by Chemical Modification of the siRNA Sequence. Methods in molecular biology. 487. 1–15. 48 indexed citations
17.
Mook, Olaf R.F., Frank Baas, Marit B. de Wissel, & Kees Fluiter. (2007). Evaluation of locked nucleic acid–modified small interfering RNAin vitroandin vivo. Molecular Cancer Therapeutics. 6(3). 833–843. 132 indexed citations
18.
Gambarota, Giulio, Andor Veltien, Hanneke W.M. van Laarhoven, et al.. (2004). Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T. Magnetic Resonance Materials in Physics Biology and Medicine. 17(3-6). 281–287. 33 indexed citations
19.
Mook, Olaf R.F., Wilma M. Frederiks, & Cornelis J.F. Van Noorden. (2003). Reply. Hepatology. 38(5). 1315–1315. 1 indexed citations
20.
Mook, Olaf R.F., Jan van Marle, Heleen Vreeling‐Sindelárová, et al.. (2003). Visualization of Early Events in Tumor Formation of Egfp–Transfected Rat Colon Cancer Cells in Liver. Hepatology. 38(2). 295–304. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Theresa Vincent Breakdown of academic impact, for papers by Kristina Rafidi Breakdown of academic impact, for papers by Vivian W.Y. Wong Breakdown of academic impact, for papers by Hilary M. Collins Breakdown of academic impact, for papers by Kristin F. Wilson Breakdown of academic impact, for papers by Praveen Bhoopathi Breakdown of academic impact, for papers by H Y Min Breakdown of academic impact, for papers by Yan Jin Breakdown of academic impact, for papers by Jialiang Hu Breakdown of academic impact, for papers by Takanori Tsuji
Rankless by CCL
2026